Variant · Snv
EP300 NM_001429.4(EP300):c.454G>A (p.Gly152Ser)
CI-VAR-00222139Explore in graph →p.Gly152SerNM_001429.4:c.454G>AClinVar 1350847 rs142758675
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1350847 | Conflicting classifications of pathogenicity | criteria provided, conflicting classifications | 1 | Colorectal cancer; Rubinstein-Taybi syndrome due to EP300 haploinsufficiency; Rubinstein-Taybi syndrome due to CREBBP mutations; Menke-Hennekam syndrome 2; Inborn genetic diseases; EP300-related disorder | germline | 5 | Oct 11, 2024 | clinvar |